- GlobeNewswire•4 days ago
BERKELEY, Calif., Feb. 16, 2017-- XOMA Corporation, a leader in the discovery and development of therapeutic antibodies, today announced the appointment of Matthew Perry, President of BVF Partners L.P., ...
- Accesswire•5 days ago
NEW YORK, NY / ACCESSWIRE / February 15, 2017 / Biotech stocks have continued to outperform the broader markets in 2017 as an easier regulatory environment and growing speculation of mergers & acquisitions ...
- Investopedia•7 days ago
Xoma announced a $25 million registered direct sale offering of common and preferred stock.
XOMA : Summary for XOMA Corporation - Yahoo Finance
XOMA Corporation (XOMA)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Bid||5.13 x 200|
|Ask||5.56 x 200|
|Day's Range||5.12 - 5.29|
|52 Week Range||0.34 - 7.62|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-2.95|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|